FDA medical adviser: 'Congress is owned by pharma' via YahooFinance
Pharmaceutical companies are under the spotlight with congressional hearings on the cost of drug prices and allegations of the industry’s role in the opioid crisis.
‘It’s really about Congress’Open Secrets, a website operated by the nonpartisan Center for Responsive Politics, tracks money in U.S. politics. It ranked the top 20 members of the House and the Senate that have received the most campaign contributions from the pharmaceutical and health products industry during the 2017-2018 election cycle.
Paul Ryan , the former speaker of the House, was ranked 10th among members of Congress. He received $222,070, seeing most of the funds coming from Merck.Beto O’Rourke , a former congressman who almost upset Senator Ted Cruz in the 2018 midterms, was 18th on the list. O’Rourke, seen as a potential 2020 Democratic presidential candidate, received $171,255.
Gillibrand announced in February 2019 that she and Senator Sherrod Brown were introducing legislation that would “penalize pharmaceutical companies believed to be engaging in price gouging without cause, leading to price spikes for patients who rely on medication to treat diseases ranging from cancer to addiction.”
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
FDA moves on vaping, drugs and food at risk with chief’s departureFDA Commissioner Scott Gottlieb was an outlier in the Trump administration, with an activist agenda touching everything from medical device regulation to youth smoking. His departure puts it all in jeopardy
Leer más »
FDA chief Scott Gottlieb's resignation leaves 'billion-dollar question' for CBD industryJust a week ago, it looked like the Food and Drug Administration was ready to revisit its policies around CBD-infused food and drinks.
Leer más »
FDA chief Gottlieb resigns as agency battles teen vaping, opioid crisisFDA Commissioner Scott Gottlieb announced his resignation yesterday after having launched an aggressive campaign against teen smoking and the opioid crisis during his time in the post. The announcement came as a surprise to many.
Leer más »
FDA Approves Johnson & Johnson’s Ketamine-Derived Drug For Treatment-Resistant DepressionThe green light means ketamine–an anesthetic abused as a party drug but promoted by some doctors without FDA approval as a necessary treatment for the most severely depressed patients—has spawned the first materially new depression treatment in decades.
Leer más »
FDA allows treatment of depression with club drug's cousinWASHINGTON (AP) — A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness.
Leer más »
Cannabis stocks tumble as FDA chief’s departure leaves CBD regulation in limboCannabis stocks fall as investors weigh the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo.
Leer más »
FDA allows genetically engineered 'Frankenfish' salmon to be imported to USAmericans are one step closer to seeing genetically modified salmon at their grocery stores.
Leer más »
FDA approves first immunotherapy regimen for breast cancerThe US Food and Drug Administration granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The drug, Genentech's Tecentriq, was approved for use in combination with Abraxane chemotherapy for patients who have a type of advanced triple negative breast cancer.
Leer más »
Claire's makeup products contain asbestos, according to FDA test resultsThe retailer disputes the findings but has pulled three products from stores 'out of an abundance of caution.'
Leer más »